19
Labeled Immunoassays Part 4 Fluorescent & Chemiluminescent Immunoassays

Labeled_Immunoassays----_Part_4

  • Upload
    resti

  • View
    2

  • Download
    0

Embed Size (px)

DESCRIPTION

immunoassays

Citation preview

  • Labeled Immunoassays
    Part 4

    Fluorescent & Chemiluminescent Immunoassays

  • Fluorescence Immunoassay

    In 1944 it was demonstrated that antibodies could be labeled with molecules that fluoresce. These fluorescent compounds are called fluorophores or fluorochromes. They have the ability to absorb energy from an incident light and convert that energy into light of a longer wavelength and lower energy as the excited electrons return to the ground state. Each Fluorophore has a characteristic optimum absorption range. The time interval between absorption of energy and emission of fluorescence is very short and can be measured in nanoseconds.
  • Characteristics of Fluorescent molecule

    Ideally, a fluorescent molecule should:

    Exhibit high intensity, which can be distinguished easily from background fluorescence, It should also be stable, and have a high molar extinction coefficient

    (a measurement of how strongly a chemical species absorbs light at a given wavelength)

  • Types of Fluorescent molecules

    The two compounds most often used are:Fluorescein and Rhodamine, because these can be readily coupled with antigen or antibody.
  • Types of Fluorescent molecules

    Fluorescein absorbs maximally at 490 to 495 nm and emits a green color at 517 nm. It has a high intensity, good photostability, and a high quantum yield. Tetramethylrhodamine absorbs at 550 nm and emits red light at 580 to 585 nm. Because their absorbance and emission patterns differ, fluorescein and rhodamine can be used together.
  • Fluorescein

  • Heterogeneous Fluorescent Immunoassays

    Require a separation step, include the following: indirect, competitive and sandwich assays. Same principle as those of enzyme immunoassays, but in this case the label is fluorescent. Such label can be applied to either antigen or antibody.
  • Heterogeneous Fluorescent Immunoassays

    Use of solid phase is the typical means of separation in heterogeneous assays.Microbeads made of polysaccharides and polyacrylamides have been used Either antigen or antibody can be attached to the beads and reacted with analyte and a fluorescent labeled analyte. Then reaction mixture is centrifuged, the supernatant is discarded, and the beads are analyzed for fluorescence.
  • Homogenous Assays

    There is only one incubation step and no wash step, Usually competitive binding is involved. The basis for this technique is the change that occurs in the fluorescent label on antigen when it binds to specific antibody. Such changes can be related to wavelength emission, or polarity. There is a direct relationship between the amount of fluorescence measured and the amount of antigen in the patient sample. As binding of patient antigen increases, binding of the fluorescent analyte decreases and hence more fluorescence is observed.
  • Fluorescence Polarization Immunoassay (FPIA)

    With competitive binding, antigen from the specimen and antigen-fluorescein (AgF) labeled reagent compete for binding sites on the antibody. FPIA is utilized to provide accurate and sensitive measurement of small toxicology analytes such as therapeutic drugs, and drugs of abuse, toxicology and some hormones.
  • Fluorescence Polarization Immunoassay (FPIA)

    It is based on the change of polarization of fluorescent light emitted from a labeled molecule when it is bound by antibody. Incident light directed at the specimen is polarized with a lens or prism so the waves are aligned in one plane. If a molecule is small and rotates quickly enough, when it is excited by polarized light, the emitted light is unpolarized. If however the labeled molecule is bound to antibody, the molecule is unable to tumble as rapidly, and it emits an increased amount of polarized light. Thus the degree of polarized light reflects the amount of labeled analyte that is bound.
  • Fluorescence Polarization Immunoassay (FPIA)

    When polarized light is absorbed by the smaller AgF molecule the AgF has the ability to rotate its position in solution rapidly before the light is emitted as fluorescence. The emitted light will be released in a different plane of space from that in which it was absorbed and is therefore called unpolarized light.

    Emitted light

    Polarized light

    Anjtibody or Binding partner - BP

    Fluorescent analyte

    Free analyte

    Polarized light describes light waves that are only present in a single plane of space

  • Fluorescence Polarization Immunoassay (FPIA)

    With the larger sized Ab-AgF complex, the same absorbed polarized light is released as polarized fluorescence because the much larger Ab-AgF complex does not rotate as rapidly in solution. The light is released in the same plane of space as the absorbed light energy, and the detector can measure it
  • Fluorescence Polarization Immunoassay (FPIA)

    Measurement of large complexes using fluorescence, rotation, and polarized light in FPIAFPIA results in an inverse dose response curve:lower levels of patient analyte result in a higher signal (in this case, the signal is polarized light). High signal at low patient analyte levels results in a highly sensitive assay.

    490nm

  • Advantages and Disadvantages

    Advantages

    Sensitivity is higher than those of radiolabels and enzyme reactions.

    The methodology is simple and there is no need to deal with and dispose of hazardous substances.

    Disadvantages

    The main problem is the separation of the signal on the label from background fluorescence because of different organic substances normally present in serum.

    Nonspecific binding to substances in serum can cause diminishing of the signal and change the amount of fluorescence generated.

    Any bilirubin or hemoglobin present can absorb either the excitation or emission energy.

    It requires expensive dedicated instrumentation, which may limit its use in smaller laboratories.

  • Chemiluminescent Immunoassays

    Several recently developed immunoassays use the principle of chemiluminescence to follow antigen antibody combination.Chemiluminescence is the emission of light caused by a chemical reaction producing an excited molecule that decays back to its original ground state. A large number of molecules are capable of chemiluminescence, but some of the most common substances used are: luminol, acridium esters, peroxyoxalates, ruthenium derivative and dioxetanes.
  • Chemiluminescent Immunoassays

    When these substances are oxidized, typically using hydrogen peroxide and an enzyme Intermediates are produced that are of a higher energy state.
  • Chemiluminescent Immunoassays

    These intermediates spontaneously return to their original state, giving off energy in the form of light. Light emissions range from a rapid flash of light to a more continuous glow that can last for hours. Different types of instrumentation are necessary for each kind of emission.
  • Advantages and Disadvantages

    Advantages

    Have an excellent sensitivity comparable to EIA and RIA.

    Reagents are stable and relatively nontoxic.

    The sensitivity of some assays has been reported to be in the range of (10-18) to zeptomoles ( 10-21).

    Because very little reagent is used, they are inexpensive to perform.

    Detection systems basically consist of photomultiplier tubes which are simple and relatively inexpensive

    Disadvantages

    False results may be obtained if there is lack of precision in injection of the hydrogen peroxide

    If some biological materials such as urine or plasma cause diminishing of the light emission.